Brain region differences in regulation of Akt and GSK3 by chronic stimulant administration in mice

Cellular Signalling

Volumn 24, Issue 7, 2012, Pages 1398-1405

  Mines, Marjelo A ^a   Jope, Richard S ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Amphetamine; Attention deficit hyperactivity disorder; Glycogen synthase kinase 3; Methylphenidate; Stimulants

Indexed keywords

AMPHETAMINE; BETA ARRESTIN; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3ALPHA; GLYCOGEN SYNTHASE KINASE 3BETA; ISOPROTEIN; METHYLPHENIDATE; PROTEIN KINASE B; SERINE; THREONINE;

ANATOMICAL VARIATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATTENTION DEFICIT DISORDER; BRAIN CORTEX; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; HIPPOCAMPUS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

AMPHETAMINE; ANIMALS; ARRESTINS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BRAIN MAPPING; CENTRAL NERVOUS SYSTEM STIMULANTS; CEREBRAL CORTEX; CORPUS STRIATUM; GLYCOGEN SYNTHASE KINASE 3; HIPPOCAMPUS; METHYLPHENIDATE; MICE; MICE, INBRED C57BL; ONCOGENE PROTEIN V-AKT; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 84859942960     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2012.03.001     Document Type: Article

References (26)

1. Carlsson A. Science 2001, 294:1021.
2. Gainetdenov R.R., Caron M.G. Annual Review of Pharmacology and Toxicology 2003, 43:261.
3. Beaulieu J.M., Gainetdinov R.R., Caron M.G. Annual Review of Pharmacology and Toxicology 2009, 49:327.
4. DeFea K.A. Cellular Signalling 2011, 23:621.
5. Shenoy S.K., Lefkowitz R.J. Trends in Pharmacological Sciences 2011, 32:521.
6. Grimes C.A., Jope R.S. Progress in Neurobiology 2001, 65:391.
7. Frame S., Cohen P. Biochemical Journal 2001, 359:1.
8. Doble B.W., Woodgett J.R. Journal of Cell Science 2003, 116:1175.
9. Stambolic V., Woodgett J.R. Trends in Cell Biology 2006, 16:461.
10. Jope R.S., Johnson G.V. Trends in Biochemical Sciences 2004, 29:95.
11. Beaulieu J.M., Marion S., Rodriguiz R.M., Medvedev I.O., Sotnikova T.D., Ghisi V., Wetsel W.C., Lefkowitz R.J., Gainetdinov R.R., Caron M.G. Cell 2008, 132:125.
12. Beaulieu J.M., Del'guidice T., Sotnikova T.D., Lemasson M., Gainetdinov R.R. Frontiers in Molecular Neuroscience 2011, 4:38.
13. Beaulieu J.M., Sotnikova T.D., Yao W.D., Kockeritz L., Woodgett J.R., Gainetdinov R.R., Caron M.G. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:5099.
14. O'Brien W.T., Huang J., Buccafusca R., Garskof J., Valvezan A.J., Berry G.T., Klein P.S. The Journal of Clinical Investigation 2011, 121:3756.
15. Emamian E.S., Hall D., Birnbaum M.J., Karayiorgou M., Gorgos J.A. Nature Genetics 2004, 36:131.
16. Beaulieu J.M., Sotnikova T.D., Marion S., Lefkowitz R.J., Gainetdinov R.R., Caron M.G. Cell 2005, 122:261.
17. Beaulieu J.M., Tirotta E., Sotnikova T.D., Masri B., Salahpour A., Gainetdinov R.R., Borrelli E., Caron M.G. Journal of Neuroscience 2007, 27:881.
18. Sutton L.P., Rushlow W.J. The International Journal of Neuropsychopharmacology 2011, 1.
19. Souza B.R., Romano-Silva M.A., Tropepe V. Journal of Neuroscience 2011, 31:5512.
20. Miller J.S., Tallarida R.J., Unterwald E.M. Neuropharmacology 2009, 56:1116.
21. DeFea K.A., Zalevsky J., Thoma M.S., Déry O., Mullins R.D., Bunnett N.W. The Journal of Cell Biology 2000, 148:1267.
22. Roudabush L.M., Choy E.W., Miller W.E., Field M.E., Pierce K.L., Lefkowitz R.J. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:2449.
23. Pascoli V., Valjent E., Corbillé A.G., Corvol J.C., Tassin J.P., Girault J.A., Hervé D. Molecular Pharmacology 2005, 68:421.
24. McGinty J.F., Shi X.D., Schwendt M., Saylor A., Toda S. Journal of Neurochemistry 2008, 104:1440.
25. Shi X., McGinty J.F. Journal of Neurochemistry 2007, 103:706.
26. Zhai H., Li Y., Wang X., Lu L. Cellular and Molecular Neurobiology 2008, 28:157.